Avigan administration is a game of speed. Can it be used in “suspected infection” prior to PCR testing? -English-

Avigan, developed as a treatment for the new flu, is a drug that prevents the growth of the virus in the body. It has been discussed whether it could be used in the “suspected infection” phase prior to PCR testing, which has also attracted attention as a treatment for a new type of corona. Because it’s important to administer it early to get the benefits.

Professor Emeritus Kimiyasu Shiraki of the University of Toyama, who co-developed Avigan with Fujifilm Toyama Chemical, reported in the March 28 (2020) issue of Nihon Medical Journal.

Starting Abigan treatment by the sixth day of onset would prevent the virus from disappearing quickly, coughing and pneumonia from progressing and becoming more severe, thereby drastically reducing the mortality rate.

A research team at Wuhan University in China announced that “116 patients under the age of 18 within 12 days of onset of the disease were treated with abigan, and 70% recovered within seven days (only those with mild disease).

>くすりの厚生会 県内2店舗

くすりの厚生会 県内2店舗

〒030-0803 青森県青森市安方1丁目3−3
Tel 017-722-4421

〒036-8003 青森県弘前市大字駅前町11−5
Tel 0172-36-5571